| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.028 | 0.8 |